RecruitingPhase 3NCT07020819
An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)
Studying Functional variant of Guillain-Barré syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Annexon, Inc.
- Principal Investigator
- Clinical TrialsAnnexon, Inc.
- Intervention
- Tanruprubart(drug)
- Enrollment
- 30 enrolled
- Eligibility
- 12-85 years · All sexes
- Timeline
- 2025 – 2028
Study locations (9)
- HonorHealth Bob Bové Neuroscience Institute, Scottsdale, Arizona, United States
- Children's Hospital of Orange County, Orange, California, United States
- University of California Irvine, Orange, California, United States
- University of Colorado Hospital, Aurora, Colorado, United States
- Ochsner LSU Health, Shreveport, Louisiana, United States
- University Massachusetts Chan Medical School, Worcester, Massachusetts, United States
- Henry Ford Health, Detroit, Michigan, United States
- Mayo Rochester, Rochester, Minnesota, United States
- Aarhus University Hospital, Aarhus, Aarhus N, Denmark
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07020819 on ClinicalTrials.govOther trials for Functional variant of Guillain-Barré syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06996509Noninvasive Support for Acute Respiratory Failure in Guillain-Barré SyndromeAssiut University
- RECRUITINGNCT06612242Early vs. Late Tracheostomy in Patients With Guillain -Barre SyndromeMeir Medical Center
- RECRUITINGNANCT06167239Ventilator Trigger Sensitivity Adjustment Versus Threshold Inspiratory Muscle Training on Arterial Blood GasesCairo University
- RECRUITINGNCT04829526Firm Observational Clinical Unicenter Study on Guillain Barré SyndromeUniversity Hospital, Basel, Switzerland
See all trials for Functional variant of Guillain-Barré syndrome →